PerspectivePublished 8 Aug 2022
Omalizumab for Treatment of Idiopathic Angioedema
Subjects
Immunology & MicrobiologyFollow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Allergy & Therapy
- SubjectImmunology & Microbiology
- BylineArticles whose byline prints “Breschi Schwartz”
